Effects of Long-Term, Medically Supervised, Drug-Free Treatment and Methadone Maintenance Treatment on Drug Users' Emergency Department Use and Hospitalization

Clinical Infectious Diseases

Volumn 37, Issue 12 SUPPL. 5, 2003, Pages

  Turner, Barbara J ^a,d   Laine, Christine ^b   Yang, Chuya P ^a   Hauck, Walter W ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Ctr Res Med Educ and Hlth Care   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; AGED; ARTICLE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG FREE TREATMENT; EMERGENCY WARD; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH STATUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; RISK; UNITED STATES;

ADULT; DELIVERY OF HEALTH CARE; EMERGENCIES; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOSPITALIZATION; HUMANS; LONG-TERM CARE; MALE; METHADONE; MIDDLE AGED; NARCOTICS; SUBSTANCE-RELATED DISORDERS;

EID: 0346218063     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377558     Document Type: Article

References (37)

1. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284:1689-95.
2. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among in-and out-of-treatment intravenous drug users: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993; 6:1049-56.
3. Caplehorn JR, Dalton MS, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89:203-9.
4. Effective medical treatment of heroin addiction. NIH consensus development conference. Bethesda, MD: National Institutes of Health, Office of the Medical Director, 17-19 November 1997.
5. Newschaffer CJ, Zhang D, Hauck WW, Fanning TR, Turner BJ. Effect of enhanced prenatal and HIV-focused services for HIV-infected pregnant women on emergency department use. Med Care 1999; 37:1308-19.
6. Laine CL, Zhang D, Gourevitch MN, Rothman J, Hauck WW, Turner BJ. Association of regular outpatient medical and drug abuse care with hospitalization of persons who use illicit drugs. JAMA 2001; 285:2355-62.
7. Keyes M, Andrews R, Mason ML. A methodology for building an AIDS research file using Medicaid claims and administrative data bases. J Acquir Immune Defic Syndr 1991; 4:1015-24.
8. Fanning TR, Turner BJ, Cosler LE, et al. Quality of Medicaid data for HIV/AIDS: examination of a statewide database. AIDS Public Policy J 1995; 10:39-47.
9. Turner BJ, McKee L, Silverman NS, Hauck WW, Fanning T, Markson LE. Prenatal care and birth outcomes of a cohort of HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:259-67.
10. Markson LE, Houchens R, Fanning TR, Turner BJ. Repeated emergency department use by persons with advanced HIV infection: effect of clinic accessibility and expertise in HIV care. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:35-41.
11. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag, 1991.
12. Rawson RA, Shoptaw SJ, Obert JL, et al. An intensive outpatient approach for cocaine abuse treatment. J Subst Abuse Treat 1995; 12:117-27.
13. Turner BJ, McKee L, Fanning T, Markson LE. AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use. Med Care 1994; 32:902-16.
14. Designated care programs for patients with AIDS and HIV-related illnesses in designated care centers. N Y State J Med 1989; 89:542-3.
15. Memorandum [Health Facilities Series H-23, D&TC-17, HMO-16]. Albany, NY: State of New York, Department of Health, 1993:93-6.
16. Stein MD. Injected-drug use: complications and costs in the care of hospitalized HIV-infected patients. J Acquir Immune Defic Syndr 1994; 7:469-73.
17. Kopstein A. Drug abuse related emergency room episodes in the United States. Br J Addict 1992; 87:1071-5.
18. Makower RM, Pennycook AG, Moulton C. Intravenous drug abusers attending an inner city accident and emergency department. Arch Emerg Med 1992; 9:32-9.
19. Fleishman JA, Hsia DC, Hellinger FJ. Correlates of medical service utilization among people with HIV infection. Health Serv Res 1994; 29:527-48.
20. Fox K, Merrill JC, Chang H, Califano JA. Estimating the cost of substance abuse to the Medicaid Hospital Care Program. Am J Pub Health 1995; 85:48-54.
21. Frank B, Galea J. Cocaine trends and other drug trends in New York City, 1986-1994. J Addict Dis 1996; 15:1-12.
22. Colliver JD, Kopstein AN. Trends in cocaine abuse reflected in ER episodes reported to DAWN. Drug Abuse Warning Network. Public Health Rep 1991; 106:59-68.
23. Smart RG, Adlaf EM. Trends in treatment admissions for cocaine and other drug abusers. Can J Psychiatry 1990; 35:621-3.
24. Gossop M, Butron M, Molla M. High dose cocaine use in Bolivia and Peru. Bull Narc 1994; 46:25-33.
25. Nappo SA, Galduroz JC, Raymundo M, Carlini EA. Changes in cocaine use as viewed by key informants: a qualitative study carried out in 1994 and 1999 in Sao Paulo, Brazil. J Psychoactive Drugs 2001; 33:241-53.
26. Libonatti O, Lima E, Peruga A, Gonzalez R, Zacarias F, Weissenbacher M. Role of drug injection in the spread of HIV in Argentina and Brazil. Int J STD AIDS 1993; 4:135-41.
27. Hoffman JA, Klein H, Eber M, Crosby H. Frequency and intensity of crack use as predictors of women's involvement in HIV-related sexual risk behaviors. Drug Alcohol Depend 2000; 58:227-36.
28. Cross JC, Johnson BD, Davis WR, Liberty HJ. Supporting the habit income generation activities of frequent crack users compared with frequent users of other hard drugs. Drug Alcohol Depend 2001; 64:191-201.
29. Ferri CP, Gossop M, Laranjeira RR. High dose cocaine use in Sao Paulo: a comparison of treatment and community samples. Subst Use Misuse 2001; 36:237-55.
30. Grisso JA, Schwarz DF, Hirschinger N, et al. Violent injuries among women in an urban area. N Engl J Med 1999; 341:1899-905.
31. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD. A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 1999; 56:507-14.
32. Schneider R, Mittelmeier C, Gadish D. Day versus inpatient treatment for cocaine dependence: an experimental comparison. J Ment Health Adm 1996; 23:234-45.
33. Alterman AI, O'Brien CP, McLellan AT, et al. Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. J Nerv Ment Dis 1994; 182:157-63.
34. Flynn PM, Kristiansen PL, Porto JV, Hubbard RL. Costs and benefits of treatment for cocaine addiction in DATOS. Drug Alcohol Depend 1999; 57:167-74.
35. McGeary KA, French MT. Illicit drug use and ER utilization. Health Serv Res 2000; 35:153-69.
36. Palepu A, Tyndall MW, Leon H, et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ 2001; 165:415-20.
37. Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS 1998; 12:417-24.